These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10286738)

  • 1. Defining alternative therapies.
    Sheldon M; Schwarz MR
    Bus Health; 1988 Apr; 5(6):30-1. PubMed ID: 10286738
    [No Abstract]   [Full Text] [Related]  

  • 2. Alternative health care finds new ground.
    Finando SJ
    Bus Health; 1988 Apr; 5(6):34-6. PubMed ID: 10286739
    [No Abstract]   [Full Text] [Related]  

  • 3. NCHCT could impede health care advancement and delivery.
    Boyle JF
    Med Instrum; 1981; 15(5):296-8. PubMed ID: 7321924
    [No Abstract]   [Full Text] [Related]  

  • 4. Who pays for new technology?
    Kirchner M
    Bus Health; 1991 Oct; 9(11):20, 22, 24-5. PubMed ID: 10115053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical insurance, technological change, and welfare.
    Goddeeris JH
    Econ Inq; 1984 Jan; 22(1):56-7. PubMed ID: 10265032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Greetings from the American Medical Association.
    Dawson JH
    Trans Assoc Life Insur Med Dir Am; 1990; 73():24-5. PubMed ID: 2112799
    [No Abstract]   [Full Text] [Related]  

  • 7. Health technology assessment: for whom the bell tolls?
    Garattini L; Casadei G
    Eur J Health Econ; 2008 Nov; 9(4):311-2. PubMed ID: 18543010
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of technology in the long-term care for the aged.
    Haber PA
    Med Instrum; 1982; 16(1):7-8. PubMed ID: 6801444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlling health care costs by controlling technology: a private contractual approach.
    Kalb PE
    Yale Law J; 1990 Mar; 99(5):1109-26. PubMed ID: 11652000
    [No Abstract]   [Full Text] [Related]  

  • 10. AMA offers technology assessment program.
    McGivney WT
    Physician Exec; 1989; 15(6):33-4. PubMed ID: 10313406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental treatment: who pays?
    Lenow JL; Quentzel S
    Bus Health; 1991 Oct; 9(11):104-5. PubMed ID: 10115050
    [No Abstract]   [Full Text] [Related]  

  • 12. Delivery of health care in South Carolina.
    Miller BN
    J S C Med Assoc; 1971 May; 67(5):237-9. PubMed ID: 5280932
    [No Abstract]   [Full Text] [Related]  

  • 13. The American Medical Association and technology assessment.
    Smith WJ
    R I Med J (1976); 1984 Mar; 67(3):113-5. PubMed ID: 6587508
    [No Abstract]   [Full Text] [Related]  

  • 14. Health care in the 21st century.
    Nelson JC
    N Engl J Med; 2005 May; 352(18):1927-8. PubMed ID: 15877324
    [No Abstract]   [Full Text] [Related]  

  • 15. The mandate for investigational cancer therapies.
    Brown E
    Physician Exec; 1995 Sep; 21(9):46-7. PubMed ID: 10151483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consolidation in health care.
    Palmisano DJ
    Health Aff (Millwood); 2005; 24(2):566. PubMed ID: 15757945
    [No Abstract]   [Full Text] [Related]  

  • 17. The private medical practitioner of the 1970s: master or slave of the American health industry.
    Weiss GN
    J La State Med Soc; 1971 Apr; 123(4):128-33. PubMed ID: 4995871
    [No Abstract]   [Full Text] [Related]  

  • 18. The limited regulatory potential of medical technology assessment.
    Elhauge E
    Va Law Rev; 1996 Nov; 82(8):1525-1622. PubMed ID: 16715565
    [No Abstract]   [Full Text] [Related]  

  • 19. Medical technology and the reimbursement dilemma.
    Dragalin D
    Internist; 1992 Oct; 33(9):12-4. PubMed ID: 10121371
    [No Abstract]   [Full Text] [Related]  

  • 20. The trouble with medical innovation.
    Moskowitz DB
    Bus Health; 1999 May; 17(5):38-42. PubMed ID: 10387675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.